Pathogenesis of progressive multifocal leukoencephalopathy - Revisited

Journal of Infectious Diseases

Volumn 203, Issue 5, 2011, Pages 578-586

  White, Martyn K ^a   Khalili, Kamel ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFALIZUMAB; IMMUNOMODULATING AGENT; NATALIZUMAB; RITUXIMAB; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; CHILDHOOD; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; JC VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; VIREMIA; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANTIBODIES, VIRAL; HUMANS; IMMUNE TOLERANCE; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; PALATINE TONSIL; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 79751493943     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq097     Document Type: Review

References (72)

1. Åström KE, Mancall EL, Richardson EP. Progressive multifocal encephalopathy: a hitherto unrecognized complication of chronic lymphocytic leukemia and lymphoma. Brain 1958; 81:99-111.
2. Schwerdt PR, Schwerdt CE, Silverman L, Rubinstein LJ. Virions associated with progressive multifocal leukoencephalopathy. Virology 1966; 29:511-4.
3. Silverman L, Rubinstein LJ. Electron microscopic observations on a case of progressive multifocal leukoencephalopathy. Acta Neuropathologica 1965; 5:215-24.
4. ZuRhein GM. Polyoma-like virions in a human demyelinating disease. Acta Neuropathol 1967; 8:57-68.
5. ZuRhein GM, Chow SM. Particles resembling papovavirions in human cerebral demyelinating disease. Science 1965; 148:1477-9.
6. Padgett BL, Zu Rhein GM, Walker DL, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet 1971; 1:1257-60.
7. Khalili K, Safak M, Del Valle L, White MK. JC virus molecular biology and the human demyelinating disease, progressive multifocal leukoencephalopathy. In: Shoshkes Reiss C ed. Neurotropic virus infections. Cambridge, United Kingdom: Cambridge University Press, 2008:190-211.
8. White MK, Safak M, Khalili K. Regulation of gene expression in primate polyomaviruses. J Virol 2009; 83:10846-56.
9. Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010; 9:425-37.
10. Del Valle L, White MK, Khalili K. Potential mechanisms of the human polyomavirus JC in neural oncogenesis. J Neuropathol Exp Neurol 2008; 67:729-40.
11. White MK, Khalili K. Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology 2004; 324:1-16. (Pubitemid 38737394)
12. Taguchi F, Kajioka J, Miyamura T. Prevalence rate and age acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol 1982; 26:1057-64. (Pubitemid 13149088)
13. Walker DL, Padgett BL. The epidemiology of human polyomaviruses. Prog Clin Biol Res 1983; 105:99-106.
14. Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71:115-23. (Pubitemid 37121921)
15. Kean JM, Rao S, Wang M, Garcea RL. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009; 5:e1000363.
16. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199:837-46.
17. Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin 1984; 2:299-313.
18. Berger JR, Pall L, Lanska D, Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998; 4:59-68. (Pubitemid 28081579)
19. Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 1992; 5:49-73.
20. Berger JR, Houff S. Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol Res 2006; 28:299-305. (Pubitemid 43765116)
21. Khalili K, White MK, Lublin F, Ferrante P, Berger JR. Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology 2007; 68:985-90. (Pubitemid 46569130)
22. Berger JR. Progressive multifocal leukoencephalopathy. Curr Neurol Neurosci Rep 2007; 7:461-9. (Pubitemid 350090305)
23. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy following rituximab therapy in HIV negative patients: a report of 57 cases from the Research on Adverse Drug Event and Reports (RADAR) project. Blood 2009; 113:4834-40.
24. Korman BD, Tyler KL, Korman NJ. Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists. Arch Dermatol 2009; 145:937-42.
25. Yogo Y, Kitamura T, Sugimoto C, et al. Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol 1990; 64:3139-43. (Pubitemid 20171319)
26. Frisque RJ, Bream GL, Cannella MT. Human polyomavirus JC virus genome. J Virol 1984; 51:458-69. (Pubitemid 14091437)
27. Monaco MC, Jensen PN, Hou J, Durham LC, Major EO. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol 1998; 72:9918-23. (Pubitemid 28520858)
28. Kato A, Kitamura T, Takasaka T, et al. Detection of the archetypal regulatory region of JC virus from the tonsil tissue of patients with tonsillitis and tonsilar hypertrophy. J Neurovirol 2004; 10:244-9. (Pubitemid 39136619)
29. Yogo Y, Sugimoto C. The archetype concept and regulatory region rearrangement. In: Khalili K, Stoner GL, eds. Human polyomaviruses. New York: Wiley-Liss,, 2001: 127-48.
30. Yogo Y, Zhong S, Shibuya A, Kitamura T, Homma Y. Transcriptional control region rearrangements associated with the evolution of JC polyomavirus. Virology 2008; 380:118-23.
31. Bofill-Mas S, Girones R. Role of the environment in the transmission of JC virus. J Neurovirol 2003; 9(suppl 1):54-8. (Pubitemid 36656472)
32. Bofill-Mas S, Clemente-Casares P, Major EO, Curfman B, Girones R. Analysis of the excreted JC virus strains and their potential oral transmission. J Neurovirol 2003; 9: 498-507. (Pubitemid 36986816)
33. Jensen PN, Major EO. Viral variant nucleotide sequences help expose leukocytic positioning in the JC virus pathway to the CNS. J Leukoc Biol 1999; 65:428-38. (Pubitemid 29160169)
34. Laghi L, Randolph AE, Chauhan DP, et al. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci U S A 1999; 96:7484-9. (Pubitemid 29299688)
35. Ricciardiello L, Laghi L, Ramamirtham P, et al. JC virus DNA sequences are frequently present in the human upper and lower gas trointestinal tract. Gastroenterology 2000; 119:1228-35.
36. Del Valle L, White MK, Enam S, et al. Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer 2005; 103:516-27.
37. Ricciardiello L, Chang DK, Laghi L, Goel A, Chang CL, Boland CR. Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues. J Virol 2001; 75:1996-2001. (Pubitemid 32110191)
38. Brown P, Tsai T, Gajdusek DC. Seroepidemiology of human papovaviruses. Discovery of virgin populations and some unusual patterns of antibody prevalence among remote peoples of the world. Am J Epidemiol 1975; 102:331-40.
39. Clayson ET, Brando LV, Compans RW. Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis. J Virol 1989; 63:2278-88. (Pubitemid 19107825)
40. Dörries K, Vogel E, Günther S, Czub S. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 1994; 198:59-70.
41. White FA 3rd, Ishaq M, Stoner GL, Frisque RJ. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 1992; 66:5726-34.
42. Elsner C, Dörries K. Evidence of human polyomavirus BK and JC infection in normal brain tissue. Virology 1992; 191:72-80.
43. Greenlee JE, Clawson SA, Carney HC, O'Neill FJ. Detection of JC virus early region sequences of brains of individuals without progressive multifocal leukoencephalopathy. Ann Neurol 2005; 28(suppl 9):S61.
44. Mori M, Kurata H, Tajima M, Shimada H. JC virus detection by in situ hybridization in brain tissue from elderly patients. Ann Neurol 1991; 29:428-32.
45. Mori M, Aoki N, Shimada H, Tajima M, Kato K. Detection of JC virus in the brains of aged patients without progressive multifocal leukoencephalopathy by the polymerase chain reaction and Southern hybridization analysis. Neurosci Lett 1992; 141:151-5.
46. Perez-Liz G, Del Valle L, Gentilella A, Croul S, Khalili K. Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann Neurol 2008; 64:379-87.
47. Ciappi S, Azzi A, De Santis R, et al. Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid. J Gen Virol 1999; 80:1017-23. (Pubitemid 29179063)
48. Tan CS, Dezube BJ, Bhargava P, et al. Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis 2009; 199:881-8.
49. Myers C, Frisque RJ, Arthur RR. Direct isolation and characterization of JC virus from urine samples of renal and bone marrow transplant patients. J Virol 1989; 63:4445-9. (Pubitemid 19229448)
50. Yogo Y, Kitamura T, Sugimoto C, et al. Sequence rearrangement in JC virus DNAs molecularly cloned from immunosuppressed renal transplant patients. J Virol 1991; 65:2422-8.
51. Pietropaolo V, Videtta M, Fioriti D, et al. Rearrangement patterns of JC virus noncoding control region from different biological samples. J Neurovirol 2003; 9:603-11. (Pubitemid 37536716)
52. Vaz B, Cinque P, Pickhardt M, Weber T. Analysis of the transcriptional control region in progressive multifocal leukoencephalopathy. J Neurovirol 2000; 6:398-409.
53. Ferrante P, Delbue S, Pagani E, et al. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment. J Neurovirol 2003; 9(suppl 1):42-6. (Pubitemid 36656470)
54. Marzocchetti A, Wuthrich C, Tan CS, et al. Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy. J Neurovirol 2008; 14:455-8. (Pubitemid 352762885)
55. Newman JT, Frisque RJ. Detection of archetype and rearranged variants of JC virus in multiple tissues from a pediatric PML patient. J Med Virol 1997; 52: 243-52. (Pubitemid 27305741)
56. Delbue S, Sotgiu G, Fumagalli D, et al. A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine. J Neurovirol 2005; 11:51-7. (Pubitemid 40458371)
57. Gallia GL, Houff SA, Major EO, Khalili K. Review: JC virus infection of lymphocytes-revisited. J Infect Dis 1997; 176:1603-9. (Pubitemid 27518163)
58. Berger JR, Houff SA, Major EO. Monoclonal antibodies and progressive multifocal leukoencephalopathy. mAbs 2009; 1: 583-9.
59. Ranganathan PN, Khalili K. The transcriptional enhancer element, kappa B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res 1993; 21:1959-64. (Pubitemid 23178916)
60. Mayreddy RP, Safak M, Razmara M, Zoltick P, Khalili K. Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells. J Virol 1996; 70:2387-93. (Pubitemid 26087602)
61. Safak M, Gallia GL, Khalili KA. 23-bp sequence element from human neurotrophic JC virus is responsive to NF-kappa B subunits. Virology 1999; 262:178-89. (Pubitemid 29455015)
62. Romagnoli L, Wollebo HS, Deshmane SL, et al. Modulation of JC virus transcription by C/EBPβ. Virus Res 2009; 146:97-106.
63. Sadowska B, Barrucco R, Khalili K, Safak M. Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J Virol 2003; 77:665-72. (Pubitemid 36005003)
64. Romagnoli L, Sariyer IK, Tung J, et al. Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology 2008; 375: 331-41.
65. Tada H, Rappaport J, Lashgari M, Amini S, Wong-Staal F, Khalili K. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci U S A 1990; 87:3479-83.
66. Daniel DC, Kinoshita Y, Khan MA, et al. Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. DNA Cell Biol 2004; 23:858-67. (Pubitemid 39628294)
67. Major EO. Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies. Annu Rev Med 2010; 61:35-47.
68. Wüthrich C, Kesari S, Kim WK, et al. Characterization of lymphocytic infiltrates in progressive multifocal leukoencephalopathy: co-localization of CD8+ T cells with JCV-infected glial cells. J Neurovirol 2006; 12:116-28. (Pubitemid 44590938)
69. Daniel AM, Swenson JJ, Mayreddy RP, Khalili K, Frisque RJ. Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology 1996; 216:90-101.
70. Gosert R, Kardas P, Major EO, Hirsch HH. Rearranged JC virus non-coding control regions found in progressive multifocal leukoencephalopathy increase virus early gene expression and replication rate. J Virol 2010. 84:1044856.
71. Elsner C, Dörries K. Human polyomavirus JC control region variants in persistently infected CNS and kidney tissue. J Gen Virol 1998; 79:789-99. (Pubitemid 28161953)
72. Newman JT, Frisque RJ. Identification of JC virus variants in multiple tissues of pediatric and adult PML patients. J Med Virol 1999; 58:79-86. (Pubitemid 29172126)